NG-nitro-L-arginine and its methyl-ester selectively inhibit NO synthase without affecting endothelial L-arginine transport, allowing for selective modulation of these pathways.
No takes yet. Share an insight, caveat, or question.
May enable selective NOS inhibition in preclinical models; hypothesis-generating and should not yet inform clinical practice.
Bogle et al. (1992) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: